HDAC6 Regulates Hsp90 Acetylation and Chaperone-Dependent Activation of Glucocorticoid Receptor

Kovacs, Jeffrey J., Murphy, Patrick J.M., Gaillard, Stéphanie, Zhao, Xuan, Wu, June-Tai, Nicchitta, Christopher V., Yoshida, Minoru, Toft, David O. +2 more·2005·Molecular Cell
DOI 10.1016/j.molcel.2005.04.021

Cited by (1,001)

Items 101–200 of 1,001

  1. HDACs and HDAC inhibitors in colon cancer
    John M. Mariadason · 2008 · Epigenetics
  2. Regulation of protein turnover by acetyltransferases and deacetylases
    Karin Sadoul, Cyril Boyault, M. Pabion, Saadi Khochbin · 2007 · Biochimie
  3. Role of Acetylation and Extracellular Location of Heat Shock Protein 90α in Tumor Cell Invasion
    Yonghua Yang, Rehka Rao, Jie Shen, Yun Tang, Warren C. Fiskus, John Nechtman, Peter Wisdom Atadja, Kapil N. Bhalla · 2008 · Cancer Research
  4. Hsp90, an unlikely ally in the war on cancer
    Jared James Barrott, Timothy Haystead · 2013 · FEBS Journal
  5. Histone deacetylase inhibitors as therapeutics for polyglutamine disorders
    Rachel K. Butler, Gillian P. Bates · 2006 · Nature reviews. Neuroscience
  6. Allosteric post-translational modification codes
    Nussinov, Ruth, Tsai, Chung-Jung, Xin, Fuxiao, Radivojac, Predrag · 2012 · Trends in Biochemical Sciences
  7. Understanding the role of histone deacetylase and their inhibitors in neurodegenerative disorders: current targets and future perspective
    Kumar, Vishal, Kundu, Satyabrata, Singh, Arti, Singh, Shamsher · 2022 · Current Neuropharmacology
  8. Histone Deacetylase 6 Regulates Growth Factor-Induced Actin Remodeling and Endocytosis
    Ya‐sheng Gao, Charlotte C. Hubbert, Jianrong Lu, Yi-Shan Lee, Joo‐Yong Lee, Tso‐Pang Yao · 2007 · Molecular and Cellular Biology
  9. Post-translational modifications of Hsp90 and translating the chaperone code
    Sarah J. Backe, Rebecca Sager, Mark R. Woodford, Alan M. Makedon, Mehdi Mollapour · 2020 · Journal of Biological Chemistry
  10. Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents
    Mandana Namdar, Gisela Perez, Lang Ngo, Paul A. Marks · 2010 · Proceedings of the National Academy of Sciences
  11. The Interactome of the Glucocorticoid Receptor and Its Influence on the Actions of Glucocorticoids in Combatting Inflammatory and Infectious Diseases
    Ιωάννα Πέττα, Lien Dejager, Marlies Ballegeer, Sam Lievens, Jan H. Tavernier, Karolien De Bosscher, Claude Libert · 2016 · Microbiology and Molecular Biology Reviews
  12. Ubiquitin-independent degradation of proteins by the proteasome
    Isabelle Jariel‐Encontre, Guillaume Bossis, Marc Piechaczyk · 2008 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  13. Proposal for a role of the Hsp90/Hsp70-based chaperone machinery in making triage decisions when proteins undergo oxidative and toxic damage
    William B. Pratt, Yoshihiro Morishima, Hwei‐Ming Peng, Yoichi Osawa · 2010 · Experimental Biology and Medicine
  14. Vorinostat in solid and hematologic malignancies
    David Samuel DiCapua Siegel, Mohamad A. Hussein, Chandra Prakash Belani, Francisco Robert, Evanthia Galanis, Victoria M. Richon, Jose E. Garcia-Vargas, César Sanz-Rodrı́guez, Syed Rizvi · 2009 · Journal of Hematology & Oncology
  15. Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin
    David Kaluza, Jens Krøll, Sabine Gesierich, Tso‐Pang Yao, Reinier Abraham Boon, Eduard Hergenreider, Marc Tjwa, Lothar Rössig, Edward Seto, Hellmut G. Augustin et al. · 2011 · The EMBO Journal
  16. Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group
    Thomas L. Beckers, Carmen Burkhardt, H. Wieland, Petra Gimmnich, Thomas Ciossek, Thomas M. Maier, Karl Sanders · 2007 · International Journal of Cancer
  17. Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives
    Robert Jenke, Nina Reßing, Finn K. Hansen, Achim Michael Aigner, Thomas Büch · 2021 · Cancers
  18. Chaperoning steroid hormone action
    Didier Picard · 2006 · Trends in Endocrinology and Metabolism
  19. HDAC6 inhibition enhances 17-AAG–mediated abrogation of hsp90 chaperone function in human leukemia cells
    Rekha Rao, Warren C. Fiskus, Yonghua Yang, Pearl Lee, Rajeshree Joshi, Pravina Fernandez, Aditya Mandawat, Peter Wisdom Atadja, James E. Bradner, Kapil N. Bhalla · 2008 · Blood
  20. Histone deacetylase inhibitors: A chemical genetics approach to understanding cellular functions
    Paul A. Marks · 2010 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  21. Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC)
    L. Rhoda Molife, Gerhardt Attard, Peter C.C. Fong, Vasilios Karavasilis, Alison H. M. Reid, Stephen G. Patterson, Charles E. Riggs, Celestia S. Higano, Walter Michael Stadler, William F. McCulloch et al. · 2009 · Annals of Oncology
  22. Histone deacetylases—an important class of cellular regulators with a variety of functions
    Christian Hildmann, Daniel Riester, Andreas Schwienhorst · 2007 · Applied Microbiology and Biotechnology
  23. Minireview: The Intersection of Steroid Receptors with Molecular Chaperones: Observations and Questions
    Smith, David F., Toft, David O. · 2008 · Molecular Endocrinology
  24. Requirement of HDAC6 for Transforming Growth Factor-β1-induced Epithelial-Mesenchymal Transition
    Bin Shan, Tso‐Pang Yao, Hong T. Nguyen, Ying Zhuo, Dawn R. Levy, Ross C. Klingsberg, Hui Tao, Michael L. Palmer, Kevin N. Holder, Joseph A. Lasky · 2008 · Journal of Biological Chemistry
  25. Regulation of Epidermal Growth Factor Receptor Trafficking by Lysine Deacetylase HDAC6
    Yonathan Lissanu, Philipp Sebastian Wild, Akhila Chandrashaker, Jasna Ćurak, Mirko H. H. Schmidt, Yannis L. Kalaidzidis, Natasa Milutinovic, Irina Kratchmarova, Lukas Bürkle, Michael J. Fetchko et al. · 2009 · Science Signaling
  26. New developments in Hsp90 inhibitors as anti-cancer therapeutics: Mechanisms, clinical perspective and more potential
    Yanyan Li, Tao Zhang, Steven J. Schwartz, Duxin Sun · 2009 · Drug Resistance Updates
  27. Hsp90: Breaking the Symmetry
    Matthias P. Mayer, Laura Le Breton · 2015 · Molecular Cell
  28. All-you-can-eat: autophagy in neurodegeneration and neuroprotection
    Philipp A. Jaeger, Tony Wyss‐Coray · 2009 · Molecular Neurodegeneration
  29. The ‘active life’ of Hsp90 complexes
    Chrisostomos Prodromou · 2011 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  30. Histone Deacetylases Positively Regulate Transcription through the Elongation Machinery
    Greer, Celeste B., Tanaka, Yoshiaki, Kim, Yoon Jung, Xie, Peng, Zhang, Michael Q., Park, In-Hyun, Kim, Tae Hoon · 2015 · Cell Reports
  31. Histone Deacetylase: A Potential Therapeutic Target for Fibrotic Disorders
    Maoyin Pang, Shougang Zhuang · 2010 · Journal of Pharmacology and Experimental Therapeutics
  32. HDAC6 Is Required for Epidermal Growth Factor-induced β-Catenin Nuclear Localization
    Yu Li, Xiaowu Zhang, Roberto D. Polakiewicz, Tso‐Pang Yao, Michael J. Comb · 2008 · Journal of Biological Chemistry
  33. Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6
    Angela Gibbs, Jacob A. Schwartzman, Vivianne Deng, Joshi J. Alumkal · 2009 · Proceedings of the National Academy of Sciences
  34. Histone Deacetylases
    Sabnam Parbin, Swayamsiddha Kar, Arunima Shilpi, Dipta Sengupta, Moonmoon Deb, Sandip Kumar Rath, Samir Kumar Patra · 2013 · Journal of Histochemistry & Cytochemistry
  35. Antidepressant-Like Properties of Novel HDAC6-Selective Inhibitors with Improved Brain Bioavailability
    Jeanine Jochems, Janette Boulden, Bridgin G. Lee, Julie A. Blendy, Matthew B. Jarpe, Ralph Mazitschek, John H. van Duzer, Simon S. Jones, Olivier Berton · 2013 · Neuropsychopharmacology
  36. Development of vorinostat: Current applications and future perspectives for cancer therapy
    Victoria M. Richon, Jose E. Garcia-Vargas, James S. Hardwick · 2009 · Cancer Letters
  37. The Microtubule-associated Histone Deacetylase 6 (HDAC6) Regulates Epidermal Growth Factor Receptor (EGFR) Endocytic Trafficking and Degradation
    Ya‐sheng Gao, Charlotte C. Hubbert, Tso‐Pang Yao · 2010 · Journal of Biological Chemistry
  38. Inhibition of Histone Deacetylases Promotes Ubiquitin-Dependent Proteasomal Degradation of DNA Methyltransferase 1 in Human Breast Cancer Cells
    Qun Yong Zhou, Agoston T. Agoston, Peter Wisdom Atadja, William G. Nelson, Nancy E. Davidson · 2008 · Molecular Cancer Research
  39. Comprehensive lysine acetylomes emerging from bacteria to humans
    Go-Woon Kim, Xiang‐Jiao Yang · 2010 · Trends in Biochemical Sciences
  40. Regulation of the Dynamics of hsp90 Action on the Glucocorticoid Receptor by Acetylation/Deacetylation of the Chaperone*
    Patrick J. M. Murphy, Y. Morishima, Jeffrey J. Kovacs, Tso-Pang Yao, W. Pratt · 2005 · Journal of Biological Chemistry
  41. Role of Heat Shock Proteins (HSP70 and HSP90) in Viral Infection
    Anna Lubkowska, Waldemar Wojciech Pluta, Aleksandra Strońska-Pluta, Alicja Lalko · 2021 · International Journal of Molecular Sciences
  42. From signaling pathways to microtubule dynamics: the key players
    Sandrine Etienne‐Manneville · 2009 · Current Opinion in Cell Biology
  43. Deacetylation of α-tubulin and cortactin is required for HDAC6 to trigger ciliary disassembly
    Jie Ran, Yunfan Yang, Dengwen Li, Min Liu, Jun Zhou · 2015 · Scientific Reports
  44. The small GTPases ARL-13 and ARL-3 coordinate intraflagellar transport and ciliogenesis
    Yujie Li, Qing Wei, Yuxia Zhang, Kun Ling, Jinghua Hu · 2010 · The Journal of Cell Biology
  45. A Review of Progress in Histone Deacetylase 6 Inhibitors Research: Structural Specificity and Functional Diversity
    Xinhui Zhang, Qin-Ma, Hui-Pan Wu, Mussa Yussuf Khamis, Yihan Li, Liying Ma, Hong‐Min Liu · 2021 · Journal of Medicinal Chemistry
  46. Histone Deacetylase Inhibitors: Mechanisms and Clinical Significance in Cancer: HDAC Inhibitor-Induced Apoptosis
    Sharmila Shankar, Rakesh K. Srivastava · 2007 · Advances in experimental medicine and biology
  47. Functional Activation of the Estrogen Receptor-α and Aromatase by the HDAC Inhibitor Entinostat Sensitizes ER-Negative Tumors to Letrozole
    Gauri J. Sabnis, Olga G. Goloubeva, Saranya Chumsri, Nguyen Nguyen, Saraswati V. Sukumar, Angela M. H. Brodie · 2011 · Cancer Research
  48. Targeting Histone Deacetylases for Cancer Therapy: From Molecular Mechanisms to Clinical Implications
    Zhiming Li, Wei‐Guo Zhu · 2014 · International Journal of Biological Sciences
  49. Requirement for p62 acetylation in the aggregation of ubiquitylated proteins under nutrient stress
    Zhiyuan You, Wenxue Jiang, Ling-Yun Qin, Zhou Gong, Wei Wan, Jin Li, Yusha Wang, Hongtao Zhang, Chao Peng, Tianhua Zhou et al. · 2019 · Nature Communications
  50. The role of histone deacetylases in prostate cancer
    Ata Abbas, Sanjay Gupta · 2008 · Epigenetics
  51. Mechanical cues control mutant p53 stability through a mevalonate–RhoA axis
    Eleonora Ingallina, Giovanni Sorrentino, Rebecca Bertolio, Kamil Lisek, Alessandro Zannini, Luca Azzolin, Luisa Ulloa Severino, Denis Scaini, Miguel Mano, Fiamma Mantovani et al. · 2017 · Nature Cell Biology
  52. Regulating the Regulators: The Post‐Translational Code of Class I HDAC1 and HDAC2
    Chiara V. Segré, Susanna Chiocca · 2010 · BioMed Research International
  53. HDAC6 Deacetylates and Ubiquitinates MSH2 to Maintain Proper Levels of MutSα
    Zhang, Mu, Xiang, Shengyan, Joo, Heui-Yun, Wang, Lei, Williams, Kendra A., Liu, Wei, Hu, Chen, Tong, Dan, Haakenson, Joshua, Wang, Chuangui et al. · 2014 · Molecular Cell
  54. The Hsp90 Chaperone Machinery Regulates Signaling by Modulating Ligand Binding Clefts
    William B. Pratt, Yoshihiro Morishima, Yoichi Osawa · 2008 · Journal of Biological Chemistry
  55. Chaperoning a cellular upheaval in malaria: Heat shock proteins in Plasmodium falciparum
    Pragyan Acharya, Ranjit Kumar, Utpal Shashikant Tatu · 2007 · Molecular and Biochemical Parasitology
  56. Dual Targeting of Histone Deacetylase and Topoisomerase II with Novel Bifunctional Inhibitors
    William Guerrant, Vishal Patil, Joshua C. Canzoneri, Adegboyega K. Oyelere · 2012 · Journal of Medicinal Chemistry
  57. Histone deacetylase inhibitors in hematological malignancies and solid tumors
    Pusoon Chun · 2015 · Archives of Pharmacal Research
  58. HDAC6 Regulates Glucocorticoid Receptor Signaling in Serotonin Pathways with Critical Impact on Stress Resilience
    Julie Espallergues, Sarah L. Teegarden, Avin Veerakumar, Janette Boulden, Collin Challis, Jeanine Jochems, Michael Chan, Tess L. Petersen, Evan S. Deneris, Patrick Matthias et al. · 2012 · Journal of Neuroscience
  59. Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myeloma
    Teru Hideshima, Jun Qi, Ronald M. Paranal, Weiping Tang, Edward F. Greenberg, Nathan H. West, Meaghan E. Colling, Guillermina Lucia Estiu, Ralph Mazitschek, Jennifer A. Perry et al. · 2016 · Proceedings of the National Academy of Sciences
  60. Characterization of the two catalytic domains in histone deacetylase 6
    Hua Zou, Yiqin Wu, Marc Navre, Bi‐Ching Sang · 2006 · Biochemical and Biophysical Research Communications
  61. Modulation of Histone Deacetylase 6 (HDAC6) Nuclear Import and Tubulin Deacetylase Activity through Acetylation
    Yuanjing Liu, Lirong Peng, Edward Seto, Suming Huang, Yi Qiu · 2012 · Journal of Biological Chemistry
  62. Development of a histone deacetylase 6 inhibitor and its biological effects
    Lee, Ju-Hee, Mahendran, Adaickapillai, Yao, Yuanshan, Ngo, Lang, Venta-Perez, Gisela, Choy, Megan L., Kim, Nathaniel, Ham, Won-Seok, Breslow, Ronald, Marks, Paul A. · 2013 · Proceedings of the National Academy of Sciences
  63. Dual targeting of epigenetic therapy in cancer
    Debby M.E.I. Hellebrekers, Arjan W. Griffioen, Manon van Engeland · 2006 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  64. Hydroxamic Acid Analogue Histone Deacetylase Inhibitors Attenuate Estrogen Receptor-α Levels and Transcriptional Activity: A Result of Hyperacetylation and Inhibition of Chaperone Function of Heat Shock Protein 90
    Warren C. Fiskus, Yuan Ren, Alex Mohapatra, Purva Bali, Aditya Mandawat, Rekha Rao, Bryan E. Herger, Yonghua Yang, Peter Wisdom Atadja, Jie Wu et al. · 2007 · Clinical Cancer Research
  65. The Tale of Protein Lysine Acetylation in the Cytoplasm
    Karin Sadoul, Jin Wang, Boubou Diagouraga, Saadi Khochbin · 2010 · BioMed Research International
  66. Acetylation Goes Global: The Emergence of Acetylation Biology
    Kristi L. Norris, Joo‐Yong Lee, Tso‐Pang Yao · 2009 · Science Signaling
  67. Positive and Negative Regulation of the Innate Antiviral Response and Beta Interferon Gene Expression by Deacetylation
    Inna Nusinzon, Curt M. Horvath · 2006 · Molecular and Cellular Biology
  68. HDAC6 a new cellular stress surveillance factor
    Patrick Matthias, Minoru Yoshida, Saadi Khochbin · 2008 · Cell Cycle
  69. Histone deacetylase inhibitors: insights into mechanisms of lethality
    Roberto R. Rosato, Steven Grant · 2005 · Expert Opinion on Therapeutic Targets
  70. HDAC6 α-tubulin deacetylase: A potential therapeutic target in neurodegenerative diseases
    Guoyi Li, Huiyi Jiang, Ming Chang, Hongrong Xie, Linsen Hu · 2011 · Journal of the Neurological Sciences
  71. Protein acetylation and deacetylation: An important regulatory modification in gene transcription (Review)
    Xia, Can, Tao, Yu, Li, Mingshan, Che, Tuanjie, Qu, Jing · 2020 · Experimental and Therapeutic Medicine
  72. Hypoxia-Inducible Factor-1: A Critical Player in the Survival Strategy of Stressed Cells
    Shuyang Chen, Nianli Sang · 2015 · Journal of Cellular Biochemistry
  73. Immunoepigenetics Combination Therapies: An Overview of the Role of HDACs in Cancer Immunotherapy
    Debarati Banik, Sara Moufarrij, Alejandro Villagra · 2019 · International Journal of Molecular Sciences
  74. Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors
    Michael L Bots, Inge Verbrugge, Benjamin P. Martin, Jessica M. Salmon, Margherita Ghisi, Adele Baker, Kym L. Stanley, Jake Shortt, Gert Jan Ossenkoppele, Johannes A. Zuber et al. · 2014 · Blood
  75. A Series of Potent and Selective, Triazolylphenyl-Based Histone Deacetylases Inhibitors with Activity against Pancreatic Cancer Cells and Plasmodium falciparum
    Yufeng Chen, Miriam Lopez-Sanchez, Doris N. Savoy, Daniel D. Billadeau, Geoffrey Stuart Dow, Alan P. Kozikowski · 2008 · Journal of Medicinal Chemistry
  76. The Middle Domain of Hsp90 Acts as a Discriminator between Different Types of Client Proteins
    Hawle, Patricija, Siepmann, Martin, Harst, Anja, Siderius, Marco, Reusch, H. Peter, Obermann, Wolfgang M. J. · 2006 · Molecular and Cellular Biology
  77. Development and Therapeutic Implications of Selective Histone Deacetylase 6 Inhibitors
    Jay H. Kalin, Joel A. Bergman · 2013 · Journal of Medicinal Chemistry
  78. Inhibition of Histone Deacetylase Class I but not Class II Is Critical for the Sensitization of Leukemic Cells to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Induced Apoptosis
    Satoshi Inoue, Antonello Mai, Martin J.S. Dyer, Gerald M. Cohen · 2006 · Cancer Research
  79. Loss of HDAC6, a novel CHIP substrate, alleviates abnormal tau accumulation
    Casey N. Cook, Tania F. Gendron, Kristyn Scheffel, Yari Carlomagno, Judy H. Dunmore, Michael A. Deture, Leonard Petrucelli · 2012 · Human Molecular Genetics
  80. Histone deacetylase inhibitors: gathering pace
    N CAREY, Nicholas Barrie La Thangue · 2006 · Current Opinion in Pharmacology
  81. Trend of Histone Deacetylase Inhibitors in Cancer Therapy: Isoform Selectivity or Multitargeted Strategy
    Lei Zhang, Yantao Han, Qixiao Jiang, Chunbo Wang, Xuehong Chen, Xiaoguang Li, Fuming Xu, Yuqi Jiang, Qiang Wang, Wenfang Xu · 2014 · Medicinal Research Reviews
  82. Microtubule acetylation amplifies p38 kinase signalling and anti-inflammatory IL-10 production
    Bin Wang, Yan-Hua Rao, Makoto Inoue, Rui Hao, Chun-Hsiang Lai, David J. Chen, Stacey L. McDonald, Moon-Chang Choi, Qiu Wang, Mari L. Shinohara et al. · 2014 · Nature Communications
  83. HDAC6 regulates androgen receptor hypersensitivity and nuclear localization via modulating Hsp90 acetylation in castration-resistant prostate cancer.
    Ai, Junkui, Wang, Yujuan, Dar, Javid A., Liu, June, Liu, Lingqi, Nelson, Joel B., Wang, Zhou · 2009 · Molecular Endocrinology
  84. Histone Deacetylase 6 Regulates Human Immunodeficiency Virus Type 1 Infection
    Agustı́n Valenzuela-Fernández, Susana Álvarez, Mónica Gordón‐Alonso, Marta Barrero-Villar, Ángeles Ursa, José Román Cabrero, Gerónimo Fernández, Salvador Naranjo‐Suarez, María Yáñez‐Mó, Juan Manuel Serrador et al. · 2005 · Molecular Biology of the Cell
  85. Histone deacetylases and epigenetic therapies of hematological malignancies
    Ciro Mercurio, Saverio Minucci, Pier Giuseppe Pelicci · 2010 · Pharmacological Research
  86. HDAC6 at the Intersection of Autophagy, the Ubiquitin-proteasome System, and Neurodegeneration
    Udai Bhan Pandey, Yakup Batlevi, Eric H. Baehrecke, J. Paul Taylor · 2007 · Autophagy
  87. The emerging role of SPOP protein in tumorigenesis and cancer therapy
    Yizuo Song, Yichi Xu, Chunyu Pan, Linzhi Yan, Zhiwei Peter Wang, Xueqiong Zhu · 2020 · Molecular Cancer
  88. A New Phase of Networking: The Molecular Composition and Regulatory Dynamics of Mammalian Stress Granules
    Sean R. Millar, Jie Qi Huang, Karl J. Schreiber, Yi-Cheng Tsai, Jiyun Won, Jianping Zhang, Alan M Moses, Ji‐Young Youn · 2023 · Chemical Reviews
  89. Lysine Deacetylases Hda1 and Rpd3 Regulate Hsp90 Function thereby Governing Fungal Drug Resistance
    Robbins, Nicole, Leach, Michelle D., Cowen, Leah E. · 2012 · Cell Reports
  90. Inhibition of HDAC6 Deacetylase Activity Increases Its Binding with Microtubules and Suppresses Microtubule Dynamic Instability in MCF-7 Cells
    Jayant Asthana, Sonia Kapoor, Renu Mohan, Dulal Panda · 2013 · Journal of Biological Chemistry
  91. Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases
    Margherita Brindisi, Akella Prasanth Saraswati, Simone Brogi, Sandra Gemma, Stefania Butini, Giuseppe Campiani · 2019 · Journal of Medicinal Chemistry
  92. The promise and perils of HDAC inhibitors in neurodegeneration
    Alessandro Didonna, Puneet Opal · 2014 · Annals of Clinical and Translational Neurology
  93. The application of histone deacetylases inhibitors in glioblastoma
    Rui Chen, Mengxian Zhang, Yangmei Zhou, Wenjing Guo, Ming Yi, Ziyan Zhang, Yanpeng Ding, Yali Wang · 2020 · Journal of Experimental & Clinical Cancer Research
  94. Heat shock proteins as gatekeepers of proteolytic pathways—Implications for age-related macular degeneration (AMD)
    Kai Kaarniranta, Antero Salminen, Eeva‐Liisa Eskelinen, Jürgen Kopitz · 2009 · Ageing Research Reviews
  95. Chromatin remodeling, metabolism and circadian clocks: The interplay of CLOCK and SIRT1
    Benedetto Grimaldi, Yasukazu Nakahata, Milota Kaluzová, Satoru Masubuchi, Paolo Sassone‐Corsi · 2008 · The International Journal of Biochemistry & Cell Biology
  96. HDAC6 regulates cellular viral RNA sensing by deacetylation of RIG‐I
    Su Jin Choi, Hyun‐Cheol Lee, Jaehoon Kim, Song Yi Park, Tae‐Hwan Kim, Woon‐Kyu Lee, Duk‐Jae Jang, Ji‐Eun Yoon, Young‐Il Choi, Seihwan Kim et al. · 2016 · The EMBO Journal
  97. AMPK-HDAC5 pathway facilitates nuclear accumulation of HIF-1α and functional activation of HIF-1 by deacetylating Hsp70 in the cytosol
    Shuyang Chen, Chengqian Yin, Taotao Lao, Dongming Liang, Dan He, Chenguang Wang, Nianli Sang · 2015 · Cell Cycle
  98. Loss of Deacetylation Activity of Hdac6 Affects Emotional Behavior in Mice
    Masahide Fukada, Atsuko Hanai, Atsuo Nakayama, Takayoshi Suzuki, Naoki Miyata, Ramona M. Rodriguiz, William C. Wetsel, Tso‐Pang Yao, Yoshiharu Kawaguchi · 2012 · PLoS ONE
  99. HDAC6 promotes cell proliferation and confers resistance to temozolomide in glioblastoma
    Zhihao Wang, Pengchao Hu, Fang Tang, Haiwei Lian, Xiong Chen, Yingying Zhang, Xiaohua He, Wanhong Liu, Conghua Xie · 2016 · Cancer Letters
  100. The Tubulin Code, from Molecules to Health and Disease
    Elizabeth D. McKenna, Stephanie L. Sarbanes, Steven W. Cummings, Antonina Roll‐Mecak · 2023 · Annual Review of Cell and Developmental Biology